👉Memantine dampens sustained, pathological NMDAR activity while preserving normal transmission → good tolerability; used in dementia and as adjunct where glutamatergic overactivity is suspected.
👉Ketamine transiently disrupts physiological NMDAR signalling via interneuronal disinhibition → rapid antidepressant effect with dissociative/psychotomimetic features.
I’ve covered all the above and more in the article below
🧵Is treatment response to Stimulants ‘mis’...leading to ADHD misdiagnoses? Pathomodal vs Physiomodal? 🚨1/15
Vyvanse has now overtaken Ozempic as the most prescribed agent in Australia.
That fact alone should make us pause. 🚨
1/ Prof Michael Berk has just published an important editorial in the British Journal of Psychiatry that articulates something many clinicians feel but rarely name.
It’s about treatment response and how it quietly shapes diagnosis
2/ As Prof Berk writes:
“A clinically critical but conceptually ignored step in clinical diagnosis is response to treatment.”
We don’t include it in diagnostic criteria but in practice, it carries enormous weight.